• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
  • Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Partnering to improve data quality and health equity

Partnering to improve data quality and health equity

by Terry Myerson, CEO | Jan 18, 2022 | News

Truveta and Lexis Nexis Risk Solutions partner to create the most complete, highest quality U.S. public health data platform    2022 is off to a rough start with this Omicron variant. I continue to be in awe of the healthcare community who continue to work...
Health system spotlight: Angela Yochem, EVP Chief Transformation & Digital Officer, Novant Health

Health system spotlight: Angela Yochem, EVP Chief Transformation & Digital Officer, Novant Health

by Truveta staff | Jan 11, 2022 | News

Each month, we’ll spotlight one of the many great leaders of our 20 member health systems that make up Truveta, helping us to advance our vision of saving lives with data. We’ll share their perspectives on the future of medicine, the changing role of technology in...
Introducing the Truveta platform and new COVID-19 insights

Introducing the Truveta platform and new COVID-19 insights

by Terry Myerson, CEO | Nov 9, 2021 | News

 Today I am excited to introduce the Truveta Platform for health systems and life science companies, share new insights about COVID-19 from the Truveta Platform, and welcome three new large regional health systems – Ochsner Health, Saint Luke’s Health System...
Partnering with Microsoft to accelerate our vision of Saving Lives with Data

Partnering with Microsoft to accelerate our vision of Saving Lives with Data

by Terry Myerson, CEO | Sep 29, 2021 | News

The COVID-19 global pandemic illustrates so clearly there is more information, yet less knowledge and insights than ever before. Healthcare providers and researchers need better data and faster answers to address the most challenging issues in patient care – not just...
Introducing our new Truveta brand 

Introducing our new Truveta brand 

by Truveta staff | Jul 28, 2021 | News

I first started thinking about our Truveta brand last summer. We weren’t officially a company yet. I didn’t even know if I would ultimately join the team. But after talking with CEO Terry Myerson for months, I was so inspired by the vision for Truveta and personally...
Truveta grows to more than 15% of U.S. patient care with new members, closing series A funding with nearly $100 million

Truveta grows to more than 15% of U.S. patient care with new members, closing series A funding with nearly $100 million

by Terry Myerson, CEO | Jul 13, 2021 | News

I will never forget when I first wrote the words Hello from Truveta. I was the first employee of a new startup imagined by several innovative healthcare leaders who believed that by working together we could achieve a compelling vision: Saving Lives with Data. What...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world survival outcomes for CRT and CCM therapies align with landmark trials
  • Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines
  • Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice